400
Participants
Start Date
January 31, 2006
talabostat mesylate
docetaxel
George A. Zervos, MD, Glen Head
New York Oncology Hematology, PC, Albany
Shatish A. Shah, MD, Gettysburg
Medical Oncology Associates of Wyoming Valley, PC, Kingston
Rittenhouse Hematology Oncology Associates, Philadelphia
Chester County Hematology / Oncology Services, West Chester
Maryland Oncology Hematology, PA, Columbia
Chesapeake Oncology Hematology Associates (Tate Center), Glen Burnie
Annandale-Fairfax Virginia Hematology Oncology, PC, Fairfax
Masoom Kandahari, MD, PC, Woodbridge
Peninsula Cancer Institute, Gloucester
Peninsula Cancer Institute, Williamsburg
Virginia Oncology Associates, Norfolk
Peninsula Cancer Institute, Newport News
Oncology & Hematology Associates of Southwest Virginia, Inc., Salem
Northwestern Carolina Oncology Hematology, Hickory
Charleston Hematology Oncology, PA, Charleston
Cancer Care Institute of Carolina, Aiken
Lucio Gordan, MD, Gainesville
Citrus Hematology and Oncology Center, Inverness
Nature Coast Clinical Research, LLC, Inverness
Cancer and Blood Disease Center, Lecanto
Ocala Oncology Center, Ocala
Pasco Hernando Oncology Associates PA, Brooksville
Pasco Hernando Oncology Associates, PA, New Port Richey
Jorge G. Otoya, MD, Kissimmee
Cancer Center of Florida, Ocoee
James P. Daugherty, MD, Muscle Shoals
Marshall Schreeder, MD, Huntsville
Kentucky Cancer Clinic, Hazard
Mukesh C. Bhatt, MD, Medina
Gabrail Cancer Center, Dover
Trilogy Cancer Center, Wooster
Gabrail Cancer Center, Canton
Oncology/Hematology Care, Inc., Cincinnati
Dayton Hematology and Oncology, Kettering
Indiana Hematology Oncology Consultants, Indianapolis
Northern Indiana Oncology Associates, South Bend
Michael McKenzie, DO, Clinton Township
Youssef Hanna, MD, Port Huron
Cancer Care Associates, PC, Royal Oak
Hematology Oncology Consultants, Royal Oak
Jeffrey H. Margolis, MD, Royal Oak
William Beaumont Hospital, Royal Oak
Mitchell Folbe, MD, PC, Troy
William Beaumont Hospital, Troy
Henry Ford Medical Center -- Fairlane, Dearborn
Josephine Ford Cancer Center -- Downriver, Brownstown
Michigan Hematology and Oncology Institute, Southgate
Henry Ford Health System, Detroit
Cancer and Transplant Consultants, PLC, Rochester Hills
Cancer Care Associates, Rochester Hills
Henry Ford Medical Center, West Bloomfield
Oncology Care Associates, PLLC, Saint Joseph
Billings Clinic, Billings
Joliet Oncology Hematology Associates, Joliet
Hematology Oncology Associates of Illinois, Chicago
University of Chicago, Chicago
Arch Medical Services, Inc., St Louis
St. Joseph Oncology, Inc., Saint Joseph
Kansas City Cancer Centers, Southwest, Overland Park
Medical Oncology, LLC, Baton Rouge
Cancer Care Associates, Oklahoma City
Cancer Care Associates, Tulsa
Texas Cancer Center of Mesquite, Mesquite
Texas Cancer Center (Dallas Southwest), Dallas
Mary Crowley Medical Research Center, Dallas
Texas Cancer Center, Arlington
Texas Oncology, PA, Fort Worth
US Oncology Research and Clinical Pharmacy, Fort Worth
Texas Cancer Center / Denton, Denton
Texas Oncology Cancer Center--Sugar Land, Sugar Land
Texas Oncology Cancer Center, Austin
West Texas Cancer Center, Odessa
El Paso Cancer Treatment Center, El Paso
Mile High Oncology, Denver
Rocky Mountain Cancer Centers, Denver
Hematology Oncology Associates, Phoenix
Comprehensive Cancer Centers of Nevada, Las Vegas
Swarna S. Chanduri, MD, Pomona
Warren Paroly, MD, Oceanside
Lalita Pandit, MD, Inc, Fountain Valley
Robert A. Moss, MD, FACP, Inc., Fountain Valley
Veena Charu, MD, Anaheim
Northwest Cancer Specialists, Northrup, Portland
Puget Sound Cancer Centers, Seattle
Northwest Cancer Specialists, PC, Vancouver
Jay L. Wittenkeller, MD, Spokane
Cancer Care Northwest Research, Spokane
Alaska Cancer Research, Anchorage
Southwest Cancer Care Medical Group, Poway
Medical Specialists of Fairfield, Fairfield
The Center for Cancer and Hematologic Disease, Cherry Hill
Palmetto Hematology Oncology, PC, Spartanburg
Allison Cancer Center, Midland
Paris Regional Cancer Center, Paris
Lead Sponsor
Point Therapeutics
INDUSTRY